310 related articles for article (PubMed ID: 10349841)
1. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.
Neely MD; Sidell KR; Graham DG; Montine TJ
J Neurochem; 1999 Jun; 72(6):2323-33. PubMed ID: 10349841
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction.
Neely MD; Boutte A; Milatovic D; Montine TJ
Brain Res; 2005 Mar; 1037(1-2):90-8. PubMed ID: 15777756
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of destruction of microtubule structures by 4-hydroxy-2-nonenal.
Kokubo J; Nagatani N; Hiroki K; Kuroiwa K; Watanabe N; Arai T
Cell Struct Funct; 2008; 33(1):51-9. PubMed ID: 18360009
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cellular effects of an intracellularly activated analogue of 4-hydroxynonenal.
Neely MD; Amarnath V; Weitlauf C; Montine TJ
Chem Res Toxicol; 2002 Jan; 15(1):40-7. PubMed ID: 11800596
[TBL] [Abstract][Full Text] [Related]
5. Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization.
Stewart BJ; Doorn JA; Petersen DR
Chem Res Toxicol; 2007 Aug; 20(8):1111-9. PubMed ID: 17630713
[TBL] [Abstract][Full Text] [Related]
6. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
Di Domenico F; Tramutola A; Butterfield DA
Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
[TBL] [Abstract][Full Text] [Related]
7. Low glutathione level favors formation of DNA adducts to 4-hydroxy-2(E)-nonenal, a major lipid peroxidation product.
Falletti O; Douki T
Chem Res Toxicol; 2008 Nov; 21(11):2097-105. PubMed ID: 18847228
[TBL] [Abstract][Full Text] [Related]
8. βPix-d promotes tubulin acetylation and neurite outgrowth through a PAK/Stathmin1 signaling pathway.
Kwon Y; Jeon YW; Kwon M; Cho Y; Park D; Shin JE
PLoS One; 2020; 15(4):e0230814. PubMed ID: 32251425
[TBL] [Abstract][Full Text] [Related]
9. Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal.
Zhang S; Eitan E; Mattson MP
J Neurochem; 2017 Mar; 140(6):941-954. PubMed ID: 28095639
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease.
Fukuda M; Kanou F; Shimada N; Sawabe M; Saito Y; Murayama S; Hashimoto M; Maruyama N; Ishigami A
Biomed Res; 2009 Aug; 30(4):227-33. PubMed ID: 19729853
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization.
Nathan BP; Chang KC; Bellosta S; Brisch E; Ge N; Mahley RW; Pitas RE
J Biol Chem; 1995 Aug; 270(34):19791-9. PubMed ID: 7649988
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.
Lee SH; Takahashi R; Goto T; Oe T
Chem Res Toxicol; 2010 Nov; 23(11):1771-85. PubMed ID: 20977208
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effect of oxidative stress on the cytoskeleton in human cortical neurons.
Allani PK; Sum T; Bhansali SG; Mukherjee SK; Sonee M
Toxicol Appl Pharmacol; 2004 Apr; 196(1):29-36. PubMed ID: 15050405
[TBL] [Abstract][Full Text] [Related]
14. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Butterfield DA
Free Radic Biol Med; 2007 Feb; 42(3):371-84. PubMed ID: 17210450
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal.
VanWinkle WB; Snuggs M; Miller JC; Buja LM
Cell Motil Cytoskeleton; 1994; 28(2):119-34. PubMed ID: 8087871
[TBL] [Abstract][Full Text] [Related]
16. Cytoskeletal modifications induced by 4-hydroxynonenal.
Gadoni E; Olivero A; Miglietta A; Bocca C; Gabriel L
Cytotechnology; 1993; 11 Suppl 1():S62-4. PubMed ID: 7765307
[TBL] [Abstract][Full Text] [Related]
17. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
18. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
19. Nutrient deprivation in neuroblastoma cells alters 4-hydroxynonenal-induced stress response.
Zimmermann L; Moldzio R; Vazdar K; Krewenka C; Pohl EE
Oncotarget; 2017 Jan; 8(5):8173-8188. PubMed ID: 28030790
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.
Montine KS; Olson SJ; Amarnath V; Whetsell WO; Graham DG; Montine TJ
Am J Pathol; 1997 Feb; 150(2):437-43. PubMed ID: 9033259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]